VBIV
Income statement / Annual
Last year (2023), VBI Vaccines Inc.'s total revenue was $8.68 M,
an increase of 702.40% from the previous year.
In 2023, VBI Vaccines Inc.'s net income was -$92.84 M.
See VBI Vaccines Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
03/31/2014 |
| Operating Revenue |
$8.68 M |
$1.08 M |
$631.00 K |
$1.06 M |
$2.22 M |
$3.36 M |
$865.00 K |
$548.00 K |
$955.00 K |
$0.00 |
| Cost of Revenue |
$14.50 M
|
$11.28 M
|
$10.77 M
|
$9.17 M
|
$7.90 M
|
$4.51 M
|
$5.19 M
|
$3.67 M
|
$3.76 M
|
$0.00
|
| Gross Profit |
-$5.82 M
|
-$10.19 M
|
-$10.14 M
|
-$8.11 M
|
-$5.68 M
|
-$1.15 M
|
-$4.33 M
|
-$3.12 M
|
-$2.80 M
|
$0.00
|
| Gross Profit Ratio |
-0.67
|
-9.42
|
-16.07
|
-7.64
|
-2.56
|
-0.34
|
-5
|
-5.7
|
-2.93
|
0
|
| Research and Development Expenses |
$9.34 M
|
$15.51 M
|
$19.56 M
|
$14.86 M
|
$26.33 M
|
$38.47 M
|
$20.92 M
|
$9.97 M
|
$618.00 K
|
$0.00
|
| General & Administrative Expenses |
$42.14 M
|
$56.12 M
|
$38.34 M
|
$20.65 M
|
$14.09 M
|
$20.79 M
|
$12.03 M
|
$11.76 M
|
$6.68 M
|
$1.42 M
|
| Selling & Marketing Expenses |
-$1.99 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$40.15 M
|
$56.12 M
|
$38.34 M
|
$20.65 M
|
$14.09 M
|
$20.79 M
|
$12.03 M
|
$11.76 M
|
$6.68 M
|
$1.42 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$862.00 K
|
$3.87 M
|
| Operating Expenses |
$49.50 M
|
$71.63 M
|
$57.89 M
|
$35.51 M
|
$40.42 M
|
$59.25 M
|
$32.95 M
|
$21.73 M
|
$8.16 M
|
$5.29 M
|
| Cost And Expenses |
$63.99 M
|
$82.90 M
|
$68.66 M
|
$44.68 M
|
$48.33 M
|
$63.76 M
|
$38.15 M
|
$25.40 M
|
$11.92 M
|
$5.29 M
|
| Interest Income |
$1.66 M
|
$1.39 M
|
$372.00 K
|
$613.00 K
|
$835.00 K
|
$622.00 K
|
$0.00
|
$0.00
|
$44.00 K
|
$551.64 K
|
| Interest Expense |
$8.06 M
|
$5.22 M
|
$5.10 M
|
$3.32 M
|
$2.20 M
|
$3.25 M
|
$2.88 M
|
$324.00 K
|
$1.13 M
|
$0.00
|
| Depreciation & Amortization |
$1.99 M
|
$2.06 M
|
$1.84 M
|
$1.65 M
|
$1.20 M
|
$542.00 K
|
$730.00 K
|
$606.00 K
|
$1.14 M
|
$30.46 K
|
| EBITDA |
-$82.78 M |
-$106.02 M |
-$62.81 M |
-$41.26 M |
-$51.41 M |
-$59.59 M |
-$36.55 M |
-$24.24 M |
-$9.52 M |
-$3.80 M |
| EBITDA Ratio |
-9.53
|
-97.99
|
-99.55
|
-38.89
|
-23.15
|
-17.76
|
-42.25
|
-44.24
|
-9.97
|
0
|
| Operating Income Ratio |
-6.37
|
-75.62
|
-107.82
|
-41.11
|
-23.59
|
-18.01
|
-43.1
|
-45.35
|
-9.25
|
0
|
| Total Other Income/Expenses Net |
-$37.53 M
|
-$31.48 M
|
-$1.72 M
|
-$2.61 M
|
-$2.41 M
|
-$3.19 M
|
-$2.15 M
|
-$135.00 K
|
-$6.05 M
|
$553.34 K
|
| Income Before Tax |
-$92.84 M
|
-$113.30 M
|
-$69.75 M
|
-$46.23 M
|
-$54.81 M
|
-$63.60 M
|
-$39.43 M
|
-$24.99 M
|
-$14.88 M
|
-$4.59 M
|
| Income Before Tax Ratio |
-10.69
|
-104.72
|
-110.54
|
-43.57
|
-24.68
|
-18.96
|
-45.58
|
-45.59
|
-15.59
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$992.00 K
|
$560.00 K
|
-$431.00 K
|
-$1.78 M
|
-$129.00 K
|
$0.00
|
| Net Income |
-$92.84 M
|
-$140.95 M
|
-$72.65 M
|
-$47.29 M
|
-$55.81 M
|
-$63.60 M
|
-$39.00 M
|
-$23.21 M
|
-$14.76 M
|
-$4.59 M
|
| Net Income Ratio |
-10.69
|
-130.27
|
-115.13
|
-44.57
|
-25.13
|
-18.96
|
-45.08
|
-42.34
|
-15.45
|
0
|
| EPS |
-5.96 |
-16.37 |
-8.55 |
-6.5 |
-14.02 |
-29.06 |
-26.49 |
-23.17 |
-35.05 |
-21.27 |
| EPS Diluted |
-5.96 |
-16.37 |
-8.55 |
-6.5 |
-14.02 |
-29.06 |
-26.49 |
-23.17 |
-35.05 |
-21.27 |
| Weighted Average Shares Out |
$15.57 M
|
$8.61 M
|
$8.50 M
|
$7.28 M
|
$3.98 M
|
$2.19 M
|
$1.47 M
|
$1.00 M
|
$421.01 K
|
$215.98 K
|
| Weighted Average Shares Out Diluted |
$15.57 M
|
$8.61 M
|
$8.50 M
|
$7.28 M
|
$3.98 M
|
$2.19 M
|
$1.47 M
|
$1.00 M
|
$421.01 K
|
$215.98 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
